EZH2 and prostate cancer: The histone methyltransferase EZH2, the catalytic subunit of Polycomb repressive complex 2 (PRC2), inhibits the transcription of downstream target genes mainly by methylation of H3K27, and it has been shown to be significantly overexpressed in NEPC compared to other prostate cancer clinical samples [54].